Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
August 7, 2023
An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor
Guiming Deng, Hao Sun, Rong Huang, et al.
Frontiers in Oncology
|
June 26, 2023
Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery
Zhongze Du, Hao Sun, Ruihu Zhao, et al.
Oncotargets and Therapy
|
May 30, 2017
Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
Li Chen, Yanjiao Zuo, Lihua Zhu, et al.
Cancer Management and Research
|
October 17, 2019
Prognostic significance of preoperative albumin-to-globulin ratio and prognostic nutritional index combined score in Siewert type 3 adenocarcinoma of esophagogastric junction
Yimin Wang, Ziyu Zhu, Chunfeng Li, et al.
International Journal of Surgery (London, England)
|
July 12, 2016
C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis
Tie Wang, Yuzhe Wei, Lining Tian, et al.
Frontiers in Pharmacology
|
July 7, 2022
The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
Li Chen, Ruihu Zhao, Hao Sun, et al.
Frontiers in Pharmacology
|
March 21, 2022
Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes
Li Chen, Hao Sun, Ruihu Zhao, et al.
Frontiers in Pharmacology
|
December 1, 2022
Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes
Li Chen, Hao Sun, Ruihu Zhao, et al.
Advanced Healthcare Materials
|
August 7, 2021
Precise Targeting Therapy of Orthotopic Gastric Carcinoma by siRNA and Chemotherapeutic Drug Codelivered in pH-Sensitive Nano Platform
Quan Wang, Yu Tian, Lei Liu, et al.
Oncotarget
|
May 13, 2015
MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1
Fei Ma, Hongjiang Song, Baoliang Guo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
August 7, 2023
An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor
Guiming Deng, Hao Sun, Rong Huang, et al.
Frontiers in Oncology
|
June 26, 2023
Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery
Zhongze Du, Hao Sun, Ruihu Zhao, et al.
Oncotargets and Therapy
|
May 30, 2017
Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
Li Chen, Yanjiao Zuo, Lihua Zhu, et al.
Cancer Management and Research
|
October 17, 2019
Prognostic significance of preoperative albumin-to-globulin ratio and prognostic nutritional index combined score in Siewert type 3 adenocarcinoma of esophagogastric junction
Yimin Wang, Ziyu Zhu, Chunfeng Li, et al.
International Journal of Surgery (London, England)
|
July 12, 2016
C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis
Tie Wang, Yuzhe Wei, Lining Tian, et al.
Frontiers in Pharmacology
|
July 7, 2022
The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
Li Chen, Ruihu Zhao, Hao Sun, et al.
Frontiers in Pharmacology
|
March 21, 2022
Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes
Li Chen, Hao Sun, Ruihu Zhao, et al.
Frontiers in Pharmacology
|
December 1, 2022
Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes
Li Chen, Hao Sun, Ruihu Zhao, et al.
Advanced Healthcare Materials
|
August 7, 2021
Precise Targeting Therapy of Orthotopic Gastric Carcinoma by siRNA and Chemotherapeutic Drug Codelivered in pH-Sensitive Nano Platform
Quan Wang, Yu Tian, Lei Liu, et al.
Oncotarget
|
May 13, 2015
MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1
Fei Ma, Hongjiang Song, Baoliang Guo, et al.
Page
of 5